Literature DB >> 11799096

Inflammatory cytokines stimulate adrenomedullin expression through nitric oxide-dependent and -independent pathways.

Karl-Heinz Hofbauer1, Ellen Schoof, Armin Kurtz, Peter Sandner.   

Abstract

A body of evidence indicates that the production of adrenomedullin (ADM) in vivo is activated in states of inflammation. Our aim was to characterize the intracellular signaling pathways along which inflammation leads to a stimulation of ADM expression. For this purpose, we characterized the effects of inflammatory cytokines, tumor necrosis factor-alpha (100 microg/L), interleukin-1beta (20 microg/L), and interferon-gamma (0.5 U/L) on ADM gene expression in rat aortic vascular smooth muscle cells (AVSMCs). We found that inflammatory cytokines induced a time-dependent 12-fold upregulation of ADM mRNA in AVSMCs that was paralleled by a substantial increase in inducible NO synthase mRNA expression. The stimulatory effect of cytokines on ADM gene expression was attenuated by NO deprivation induced by Nomega-nitro-L-arginine methyl ester (1 mmol/L) and was in part mimicked by the NO donor S-nitroso-N-acetylpenicillamine (100 micromol/L). The cGMP analog 8-bromo-cGMP (100 micromol/L) had no effect on ADM gene expression, and inhibition of cGMP production by 1H-oxodiazolo-quinoxalin-1 (ODQ, 200 micromol/L) was not able to abrogate the increase of ADM mRNA induced by NO donation using S-nitroso-N-acetylpenicillamine (100 micromol/L). The significant induction of ADM gene expression by inflammatory cytokines and NO donation was also observed in mesangial cells, endothelial cells, and hepatocytes. These findings suggest that NO is a direct activator of ADM gene expression in a variety of cell types and that inflammatory cytokines stimulate ADM expression via both NO-dependent and -independent mechanisms. The stimulatory effect of NO appears to not be related to the classic guanylate cyclase-cGMP pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11799096     DOI: 10.1161/hy1201.097201

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  9 in total

1.  Role of adrenomedullin in Lyme disease.

Authors:  Meghan L Marre; Courtney T Darcy; Janeth Yinh; Shizuo Akira; Satoshi Uematsu; Allen C Steere; Linden T Hu
Journal:  Infect Immun       Date:  2010-10-04       Impact factor: 3.441

2.  The incidence of new onset congestive heart failure and heart failure exacerbation in Veteran's Affairs patients receiving tumor necrosis factor alpha antagonists.

Authors:  Jennifer Cole; Anthony Busti; Salahuddin Kazi
Journal:  Rheumatol Int       Date:  2006-10-07       Impact factor: 2.631

3.  Elevated levels of adrenomedullin in eutopic endometrium and plasma from women with endometriosis.

Authors:  Brooke C Matson; Kelsey E Quinn; Bruce A Lessey; Steven L Young; Kathleen M Caron
Journal:  Fertil Steril       Date:  2018-06-02       Impact factor: 7.329

Review 4.  Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad.

Authors:  Pietro Enea Lazzerini; Pier Leopoldo Capecchi; Mauro Galeazzi; Franco Laghi-Pasini
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

5.  Effect of hyperglycaemia on inflammatory and stress responses and clinical outcome of pneumonia in non-critical-care inpatients: results from an observational cohort study.

Authors:  Philipp Schuetz; Natalie Friedli; Eva Grolimund; Alexander Kutz; Sebastian Haubitz; Mirjam Christ-Crain; Robert Thomann; Werner Zimmerli; Claus Hoess; Christoph Henzen; Beat Mueller
Journal:  Diabetologia       Date:  2013-11-24       Impact factor: 10.122

6.  The expression and regulation of adrenomedullin in the human endometrium: a candidate for endometrial repair.

Authors:  Jacqueline A Maybin; Sharon Battersby; Nikhil Hirani; Leonid L Nikitenko; Hilary O D Critchley; Henry N Jabbour
Journal:  Endocrinology       Date:  2011-05-10       Impact factor: 4.736

7.  Adiponectin Attenuates Angiotensin II-Induced Vascular Smooth Muscle Cell Remodeling through Nitric Oxide and the RhoA/ROCK Pathway.

Authors:  Wared Nour-Eldine; Crystal M Ghantous; Kazem Zibara; Leila Dib; Hawraa Issaa; Hana A Itani; Nabil El-Zein; Asad Zeidan
Journal:  Front Pharmacol       Date:  2016-04-07       Impact factor: 5.810

8.  Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial.

Authors:  Pierre-François Laterre; Peter Pickkers; Gernot Marx; Xavier Wittebole; Ferhat Meziani; Thierry Dugernier; Vincent Huberlant; Tobias Schuerholz; Bruno François; Jean-Baptiste Lascarrou; Albertus Beishuizen; Haikel Oueslati; Damien Contou; Oscar Hoiting; Jean-Claude Lacherade; Benjamin Chousterman; Julien Pottecher; Michael Bauer; Thomas Godet; Mahir Karakas; Julie Helms; Andreas Bergmann; Jens Zimmermann; Kathleen Richter; Oliver Hartmann; Melanie Pars; Alexandre Mebazaa
Journal:  Intensive Care Med       Date:  2021-10-04       Impact factor: 17.440

9.  The usefulness of plasma levels of mature and total adrenomedullin as biomarkers indicating the magnitude of surgical stress responses: A single-center, prospective, observational study.

Authors:  Go Otao; Toyoaki Maruta; Tetsu Yonaha; Koji Igarashi; Sayaka Nagata; Kazuo Kitamura; Isao Tsuneyoshi
Journal:  J Clin Transl Res       Date:  2021-05-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.